488 related articles for article (PubMed ID: 29016910)
1. Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey.
Tilz RR; Potpara T; Chen J; Dobreanu D; Larsen TB; Haugaa KH; Dagres N
Europace; 2017 Oct; 19(10):1737-1742. PubMed ID: 29016910
[TBL] [Abstract][Full Text] [Related]
2. Left atrial appendage closure-indications, techniques, and outcomes: results of the European Heart Rhythm Association Survey.
Pison L; Potpara TS; Chen J; Larsen TB; Bongiorni MG; Blomström-Lundqvist C;
Europace; 2015 Apr; 17(4):642-6. PubMed ID: 25833883
[TBL] [Abstract][Full Text] [Related]
3. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
4. Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey.
Lip GY; Dagres N; Proclemer A; Svendsen JH; Pison L; Blomstrom-Lundqvist C;
Europace; 2013 Jan; 15(1):141-3. PubMed ID: 23233491
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous left atrial appendage occlusion: A review of current devices, clinical evidence, patient selection, and post procedural antithrombotic management.
Jackson LR; Jackson KP; Thomas KL
Prog Cardiovasc Dis; 2021; 66():92-100. PubMed ID: 34332665
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous left atrial appendage occlusion: New perspectives for the method.
Gorczyca-Michta I; Wożakowska-Kapłon B
Cardiol J; 2017; 24(5):554-562. PubMed ID: 28281734
[TBL] [Abstract][Full Text] [Related]
7. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.
Black-Maier E; Piccini JP; Granger CB
J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437
[TBL] [Abstract][Full Text] [Related]
8. Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey.
Potpara TS; Lip GY; Larsen TB; Madrid A; Dobreanu D; Jędrzejczyk-Patej E; Dagres N;
Europace; 2016 Oct; 18(10):1593-1598. PubMed ID: 27876696
[TBL] [Abstract][Full Text] [Related]
9. Use of a Novel Septal Occluder Device for Left Atrial Appendage Closure in Patients With Postsurgical and Postlariat Leaks or Anatomies Unsuitable for Conventional Percutaneous Occlusion.
Della Rocca DG; Horton RP; Tarantino N; Van Niekerk CJ; Trivedi C; Chen Q; Mohanty S; Anannab A; Murtaza G; Akella K; Gianni C; Bassiouny M; Ahmadian-Tehrani A; Al-Ahmad A; Burkhardt JD; Natale VN; Price M; Gallinghouse GJ; Gibson DN; Lakkireddy D; Di Biase L; Natale A
Circ Cardiovasc Interv; 2020 Oct; 13(10):e009227. PubMed ID: 32942913
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
11. Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication.
Aarnink EW; Maarse M; Fierro N; Mazzone P; Beneduce A; Tondo C; Gasperetti A; Pracon R; Demkow M; Zieliński K; de Backer O; Korsholm K; Nielsen-Kudsk JE; Estévez-Loureiro R; Caneiro-Queija B; Benito-González T; Pérez de Prado A; Nombela-Franco L; Salinas P; Holmes D; Almakadma AH; Berti S; Romeo MR; Millan X; Arzamendi D; Alla VM; Agarwal H; Eitel I; Paitazoglou C; Freixa X; Cepas-Guillén P; Chothia R; Badejoko SO; Spoon DB; Maddux JT; El-Chami M; Ram P; Branca L; Adamo M; Suradi HS; Peper J; van Dijk VF; Rensing BJWM; Swaans MJ; Vireca E; Bergmann MW; Boersma LVA;
JACC Cardiovasc Interv; 2024 Jun; 17(11):1311-1321. PubMed ID: 38795093
[TBL] [Abstract][Full Text] [Related]
12. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage.
Gadiyaram VK; Mohanty S; Gianni C; Trivedi C; Al-Ahmad A; Burkhardt DJ; Gallinghouse JG; Hranitzky PM; Horton RP; Sanchez JE; Della Rocca DG; Di Biase L; Price MJ; Couts L; Gibson D; Natale A
J Cardiovasc Electrophysiol; 2019 Apr; 30(4):511-516. PubMed ID: 30623500
[TBL] [Abstract][Full Text] [Related]
13. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
[TBL] [Abstract][Full Text] [Related]
14. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
Ramlawi B; Abu Saleh WK; Edgerton J
Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
[TBL] [Abstract][Full Text] [Related]
15. Left atrial appendage occlusion with the Amplatzer Cardiac Plug could improve survival and prevent thrombo-embolic and major bleeding events in atrial fibrillation patients with increased bleeding risk.
Budts W; Laenens D; Van Calenbergh F; Vermeersch P; De Potter T; Aminian A; Benit E; Stammen F; Kefer J
Acta Cardiol; 2016 Apr; 71(2):135-43. PubMed ID: 27090034
[TBL] [Abstract][Full Text] [Related]
16. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
[TBL] [Abstract][Full Text] [Related]
17. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous Left Atrial Appendage Closure: Current Devices and Clinical Outcomes.
Asmarats L; Rodés-Cabau J
Circ Cardiovasc Interv; 2017 Nov; 10(11):. PubMed ID: 29146668
[TBL] [Abstract][Full Text] [Related]
19. LAA occluder device for stroke prevention: Data on WATCHMAN and other LAA occluders.
Bergmann MW
Trends Cardiovasc Med; 2017 Aug; 27(6):435-446. PubMed ID: 28461140
[TBL] [Abstract][Full Text] [Related]
20. Device-associated thrombus formation after left atrial appendage occlusion: A systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet.
Lempereur M; Aminian A; Freixa X; Gafoor S; Kefer J; Tzikas A; Legrand V; Saw J
Catheter Cardiovasc Interv; 2017 Nov; 90(5):E111-E121. PubMed ID: 28145040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
